2 Reasons to Invest in Biogen Stock Right Now

Biotechnology stocks had a rough start to the year, but many are starting to regain lost ground. Despite this, Biogen (BIIB) shares remain weak, partly due to the company’s dismal phase 2 results for its hyped MS drug, opicanumab. While the drug’s failure is a concern, there are two good reasons to hold onto Biogen’s stock for the long-term. 1.     […]

Continue reading »

3 Reasons for Exact Sciences’ Stock Jumping 33% on Tuesday

Exact Sciences (EXAS) stock jumped 33% on Tuesday following a major announcement. The company: 1.     Hired a Baird Research Assistant The company announced that it had hired a former Baird research assistant for a key role in the company. Jeff Elliott, the research assistant, has been placed in a position with the company to seek out strategic business opportunities. 2.     […]

Continue reading »

3 Biotech Bargains to Track in June

Biotech stocks have struggled on the year as a whole, but there are a few companies that have solid revenue and earnings that are valued at a steep discount going into June. These three companies are considered undervalued and have strong financials: 1.     Ligand Pharmaceuticals (LGND) Ligand has been a driving force over the last 12 months, rising 39%. The […]

Continue reading »

Walgreens Beats Estimates, Shares Jump 3.5%

Walgreens Boots Alliance Inc. (NASDAQ:WBA) beat earnings estimates, as major trends in prescription drugs offset a slump in retail sales. Walgreens attracted shoppers by offering a better overall shopping experience and offering high-end products. In the U.S., Walgreens same-store retail sales declined 0.6% in the quarter ended on November 30 compared to the previous year. Excluding one-time items, earnings reached […]

Continue reading »